R C Bland1, S C Newman. 1. Department of Psychiatry, University of Alberta, Edmonton, Alberta. Roger.Bland@ualberta.ca
Abstract
OBJECTIVE: To examine the Modified Mini-Mental State Examination (3MS) as a screen for dementia. METHOD: A group of 1092 elderly Edmonton community residents completed the 3MS and the Geriatric Mental State Examination (GMS). 3MS sensitivity and specificity were determined by comparing positive 3MS screens (score < or = 77) with those classified as GMS "organic" (severity level 3, equivalent to a clinical diagnosis). In the Canadian Study of Health and Aging (CSHA), 2914 subjects received the 3MS and a clinical examination. A group described as having "cognitive impairment but no dementia (CIND)" was identified. RESULTS: In Edmonton, the 3MS showed 88% sensitivity, 90% specificity, 29% positive predictive value (PPV), and 99% negative predictive value (NPV). In the CSHA, 30% of subjects receiving both the 3MS and a clinical examination were classified as CIND. One-half of these were classified as having "age associated memory impairment (AAMI)" or as "unspecified." CONCLUSIONS: The 3MS with a cutting score of 77/78 proved a reasonable screening instrument; 1 case in 3 screening "positive" has dementia, but few (0.64%) will be missed by screening "negative." CIND, accounting for 2 out of 3 cases screened positive by the 3MS in the Edmonton study, is a substantial, heterogeneous group that is not necessarily "predementia" but that in many cases merits further investigation.
OBJECTIVE: To examine the Modified Mini-Mental State Examination (3MS) as a screen for dementia. METHOD: A group of 1092 elderly Edmonton community residents completed the 3MS and the Geriatric Mental State Examination (GMS). 3MS sensitivity and specificity were determined by comparing positive 3MS screens (score < or = 77) with those classified as GMS "organic" (severity level 3, equivalent to a clinical diagnosis). In the Canadian Study of Health and Aging (CSHA), 2914 subjects received the 3MS and a clinical examination. A group described as having "cognitive impairment but no dementia (CIND)" was identified. RESULTS: In Edmonton, the 3MS showed 88% sensitivity, 90% specificity, 29% positive predictive value (PPV), and 99% negative predictive value (NPV). In the CSHA, 30% of subjects receiving both the 3MS and a clinical examination were classified as CIND. One-half of these were classified as having "age associated memory impairment (AAMI)" or as "unspecified." CONCLUSIONS: The 3MS with a cutting score of 77/78 proved a reasonable screening instrument; 1 case in 3 screening "positive" has dementia, but few (0.64%) will be missed by screening "negative." CIND, accounting for 2 out of 3 cases screened positive by the 3MS in the Edmonton study, is a substantial, heterogeneous group that is not necessarily "predementia" but that in many cases merits further investigation.
Authors: Lindsay A Miller; Mary Beth Spitznagel; Michael L Alosco; Ronald A Cohen; Naftali Raz; Lawrence H Sweet; Lisa Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: J Clin Exp Neuropsychol Date: 2012-03-01 Impact factor: 2.475
Authors: Joseph W Shega; Debra K Weiner; Judith A Paice; S Pinar Bilir; Kenneth Rockwood; Keela Herr; Mary Ersek; Linda Emanuel; William Dale Journal: J Gerontol A Biol Sci Med Sci Date: 2010-03-29 Impact factor: 6.053
Authors: Breda Cullen; Brian O'Neill; Jonathan J Evans; Robert F Coen; Brian A Lawlor Journal: J Neurol Neurosurg Psychiatry Date: 2006-12-18 Impact factor: 10.154
Authors: Joseph W Shega; Melissa Andrew; Ashwin Kotwal; Denys T Lau; Keela Herr; Mary Ersek; Debra K Weiner; Marshall H Chin; William Dale Journal: J Am Geriatr Soc Date: 2013-12-09 Impact factor: 5.562
Authors: Maria C Raven; Lina Tieu; Christopher T Lee; Claudia Ponath; David Guzman; Margot Kushel Journal: Acad Emerg Med Date: 2017-01 Impact factor: 3.451
Authors: Kathleen M Hayden; Peter P Zandi; Nancy A West; Joann T Tschanz; Maria C Norton; Chris Corcoran; John C S Breitner; Kathleen A Welsh-Bohmer Journal: Arch Neurol Date: 2009-11
Authors: Heidi D Klepin; Janet A Tooze; Timothy S Pardee; Leslie R Ellis; Dmitriy Berenzon; Shannon L Mihalko; Suzanne C Danhauer; Arati V Rao; Tanya M Wildes; Jeff D Williamson; Bayard L Powell; Stephen B Kritchevsky Journal: J Am Geriatr Soc Date: 2016-09-14 Impact factor: 5.562
Authors: Michael L Alosco; Adam M Brickman; Mary Beth Spitznagel; Erica Y Griffith; Atul Narkhede; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: J Neurol Sci Date: 2013-03-23 Impact factor: 3.181